Covid-19 — House of Lords, 2021-11-15
Topic: Health
Syed Kamall (Conservative, Centre-right): My Lords, with the leave of the House, I shall now repeat a Statement made earlier in another place. The Statement is as follows: "Mr Speaker, I will start by saying a few words about the incident that took place at Liverpool Women’s Hospital yesterday. This is an ongoing investigation into what has now been declared a terrorist incident by police so it would not be appropriate for me to comment in any detail, but I express my thanks to all the NHS staff and emergency services who responded to the incident. They showed the utmost professionalism in the most difficult of circumstances and my thoughts—and, I know, the thoughts of the whole House—are with them and anyone who has been affected With permission, I shall make a statement on the Covid-19 pandemic and the life-saving work of our vaccination programme. A year ago today, we were in the midst of our second national lockdown, a time when we endured major restrictions on our life and liberty and when we observed a period of remembrance where we could not come together and pay our respects in person in the way that we would all have wanted to. Our country has come very far since then. We have put over 109 million vaccine doses in people’s arms through our world-leading vaccine programme, which means that we can approach this winter with the best possible chance of living with the virus. The data clearly demonstrates that vaccines work. This month’s figures from the ONS show that, between January and September, the risk of death involving Covid-19 was 32 times greater in unvaccinated people than in those who are fully vaccinated. However, although we have built up that huge protection, this is not a time for complacency. Earlier this month the WHO’s Europe director said that Europe was "back at the epicentre of the pandemic" Just this weekend, the Netherlands and Austria have put in place partial lockdowns after surges in cases We also still face the risk of new variants just as we have seen with the emergence of AY.4.2, the so-called delta-plus variant. The latest data shows that it now accounts for around 15% of cases in the UK. Although delta-plus may be more infectious than the original delta variant, our investigations indicate that our vaccines remain effective against it. Still, we know that there will be more variants in future, and we do not want to go backwards after all the progress we have made. So we must stay focused on the threat in front of us and seize every opportunity to bolster our vital defences as the winter moves in That includes our vaccination programme, which is our primary form of defence. Last week, I announced to the House that health and social care providers in England must make sure that all workers other than those who are medically exempt, are fully vaccinated against Covid-19 so that vulnerable patients have the greatest possible protection against infection. Today, I shall update the House on more measures that we are taking to keep ourselves on the front foot First, we are expanding our booster programme, which is essential so that we can keep upgrading our protection in this country. Our vaccination programme has given us a strong protective wall, but we need to use every opportunity to shore up our defences. Evidence published this month shows how protection against symptomatic disease, hospitalisation and death from Covid-19 gradually wanes as time passes, and this is more likely if you are older or clinically at risk. Even a small drop in immunity can mean a big impact on the NHS; if protection drops from 95% to 90% against hospitalisation in those who are double-vaccinated, that would mean a doubling of hospital admissions in that group of people, so topping up our immunity through booster doses is essential to our security for the long term Today, the UKHSA has published the first data on booster vaccine effectiveness in the UK. It shows that people who take up the offer of a booster vaccine increase their protection against symptomatic Covid-19 infection to over 90%, and protection against more severe disease is expected to be even higher. So we are intensifying the booster programme ahead of the winter. Over 12 million people have now had their top-up jab, and over 2 million were given it last week. We have also made changes to the national booking service so that people can prebook their top-up doses a month before they become eligible. Last Monday, we saw almost 800,000 bookings in a single day in England, which is a new record Secondly, we are taking another step forward. The JCVI has recommended offering all adults aged 40 to 49 a booster dose six months after their second dose, using either the Pfizer or Moderna vaccines. I have accepted that advice, and 40 to 49 year-olds will be able to get their top-up jab from next Monday if they are eligible. The JCVI has also said that, in due course, it will be considering whether boosters are needed for all 18 to 39 year-olds, along with whether additional booster doses are required for the most vulnerable over the long term. I look forward to receiving that advice in due course Just as we extend protection through booster doses, we are also ramping up our efforts to protect younger people. Our programme for 12 to 15 year-olds is progressing at pace. Yesterday, we hit the milestone of 1 million 12 to 15 year-olds being vaccinated in England. We are also offering a vaccine to 16 and 17 year-olds. I would like to update the House on some further steps that we are taking In August, we decided, in line with JCVI advice, that all 16 and 17 year-olds could be offered a first dose of a Pfizer vaccine. That was apart from a small number of those in at-risk groups who were offered two doses. Now, the JCVI has advised that all 16 and 17 year-olds should also be offered a second dose, and that it is even more confident about the safety and benefit of doses in 16 and 17 year-olds. As Dr June Raine, the chief executive of the MHRA, said this morning: "As the data have accrued, we’ve become more and more reassured that the safety picture in young people and teenagers is just the same as what we’ve seen in the older population." The JCVI advises that, unless the patient is in an at-risk group, the second dose should take place 12 weeks after the initial dose, rather than eight weeks. I have accepted that advice. The NHS will be putting it into action. Once again, these jabs will start going into arms from next Monday. This will extend the protection of a vaccine to even more people and strengthen our national defences even further Our vaccination programme has paved our path out of this pandemic and given us hope of a winter that is brighter than the last. Today, we are going even further, extending our booster programme and offering great protection to younger people, so that we can fortify the defences that we have built together and help our nation to stay one step ahead of the virus. I commend this Statement to the House."